Aqemia
✓ Verified
Healthcare AI
AI drug discovery / drug invention
Series A
Aqemia is a Paris- and London-based drug invention company and techbio founded in 2019 that combines generative AI with atomic-scale physics and quantum-inspired methods to design novel small-molecule drug candidates, with an emphasis on oncology, immuno-oncology, and other critical diseases. It partners with pharmaceutical companies such as Sanofi and also advances its own internal pipeline.
Company Details
- Website
- aqemia.com
- Headquarters
- Paris, France
- Founded
- 2019
- Funding
- Over $100M
Subscriber Intelligence
- • Deal signal alerts for this company
- • Sentiment & risk scoring
- • Competitive framework analysis
- • Regulatory event monitoring